文献速递乳房整形与再造美容整形

乳房假体包膜切除术主要并发症的发生率及术前危险因素:3048例患者分析

Incidence and Preoperative Risk Factors for Major Complications After Capsulectomy: Analysis of 3048 Patients.
PubMed 文献 · Aesthet Surg J · 2022-01-01

基于前瞻性整容手术保险数据库,2017年1月2日至2019年7月31日共评估76128例患者,其中3048例(4.0%)行包膜切除术。包膜切除术患者发生任何并发症及血肿的风险均高于未行包膜切除术的假体取出或置换患者(2.8% vs 1.9%和1.6% vs 0.9%,P < 0.05)。美国麻醉医师协会III/IV级是任何并发症的独立危险因素,BMI ≥30 kg/m2和办公室手术室是感染的危险因素。

要点

  • 包膜切除术患者任何并发症发生率为2.8%,血肿为1.6%,感染为0.5%。
  • 包膜切除术患者并发症风险高于未行包膜切除术的假体取出或置换患者。
  • 美国麻醉医师协会III/IV级、BMI ≥30 kg/m2和办公室手术室是并发症危险因素。

核心结论

  • 包膜切除术数量正在增加,最常见的主要并发症是血肿,且包膜切除术患者并发症发生率高于未行包膜切除术的假体取出或置换患者,应就主要并发症风险对患者进行告知。

研究设计与样本

  • 前瞻性整容手术保险数据库(CosmetAssure)分析,纳入2017年1月2日至2019年7月31日期间行包膜切除术的患者。

主要发现

  • 在76128例评估患者中,3048例(4.0%)行包膜切除术。
  • 2019年1月6日后包膜切除术数量显著增加(2.7例/天 vs 5.2例/天,P < 0.05)。
  • 包膜切除术患者任何并发症发生率高于未行包膜切除术的假体取出或置换患者(2.8% vs 1.9%,P < 0.05)。
  • 包膜切除术患者血肿发生率高于未行包膜切除术的假体取出或置换患者(1.6% vs 0.9%,P < 0.05)。
  • 84例(2.8%)发生至少1种并发症,最常见为血肿(1.6%),其次为感染(0.5%)。

关键数值与推荐

  • 美国麻醉医师协会III/IV级是任何并发症的独立危险因素。
  • BMI ≥30 kg/m2和办公室手术室是感染的危险因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although there are many indications for periprosthetic breast capsulectomy, heightened public attention surrounding breast implant illness has resulted in increased rates of capsulectomy. OBJECTIVES: This study aimed to identify the incidence of major complications and risk factors associated with capsulectomy. METHODS: From an examination of a prospectively enrolled cosmetic surgery insurance database, CosmetAssure (Birmingham, AL), patients undergoing capsulectomy between January 2, 2017 and July 31, 2019 were identified. Outcomes measured included the occurrence of and risk factors for major complication(s) necessitating an emergency department visit, hospitalization, or reoperation within 45 postoperative days. RESULTS: Among 76,128 patients evaluated, 3048 (4.0%) underwent capsulectomy. There was a significant increase in number of capsulectomies following January 6, 2019 (2.7/day vs 5.2/day, P < 0.05). Capsulectomy patients were more likely to have any complication and specifically hematoma than those undergoing breast implant removal or replacement without capsulectomy (2.8% vs 1.9% and 1.6% vs 0.9%, respectively, P < 0.05). Eighty-four (2.8%) developed at least 1 complication. The most common complications included hematoma (1.6%) followed by infection (0.5%). American Society of Anesthesiologists Class III/IV was an independent risk factor for any complication and BMI ≥30 kg/m2 and office-based surgical suites were risk factors for infection. CONCLUSIONS: A growing number of capsulectomies are being performed. The most common major complication is hematoma. Patients undergoing capsulectomy experience a higher complication rate than those undergoing breast implant removal or replacement without capsulectomy. Patients should be counseled regarding the potential for major complications.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Afshari A, Nguyen L, Glassman GE, et al. Incidence and Preoperative Risk Factors for Major Complications After Capsulectomy: Analysis of 3048 Patients. Aesthet Surg J. 2022. PMID: 35022655. doi:10.1093/asj/sjac004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。